Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology

This publication has 23 references indexed in Scilit:

• Planned progressive antimicrobial therapy in neutropenic patients
  British Journal of Haematology, 1998
• Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
  Antimicrobial Agents and Chemotherapy, 1995
• The changing epidemiology of bacteremia in neutropenic children with cancer
  The Pediatric Infectious Disease Journal, 1995
• Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
  Journal of Clinical Oncology, 1995
• Factors associated with bacteraemia in febrile, granulocytopenic cancer patients
  European Journal of Cancer, 1994
• Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia
  Annals of Internal Medicine, 1993
• Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia
  European Journal of Cancer, 1993
• Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.
  Journal of Clinical Oncology, 1992
• Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia
  New England Journal of Medicine, 1987